A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Conditions:   Chronic Lymphocytic Leukemia;   COVID-19 Infection Interventions:   Procedure: Biospecimen Collection;   Biological: mRNA COVID-19 Vaccine;   Biological: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials